Sarepta Therapeutics/SRPT
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX
About Sarepta Therapeutics
Ticker
SRPT
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Cambridge, United States
Employees
1,314
Website
www.sarepta.com
SRPT Metrics
BasicAdvanced
$15B
Market cap
856.46
P/E ratio
$0.18
EPS
0.94
Beta
-
Dividend rate
Price and volume
Market cap
$15B
Beta
0.94
Financial strength
Current ratio
4.049
Quick ratio
2.974
Long term debt to equity
132.519
Total debt to equity
145.197
Interest coverage (TTM)
-4.78%
Management effectiveness
Return on assets (TTM)
-1.89%
Return on equity (TTM)
2.02%
Valuation
Price to earnings (TTM)
856.46
Price to revenue (TTM)
10.31
Price to book
15.08
Price to tangible book (TTM)
15.55
Price to free cash flow (TTM)
-26.22
Growth
Revenue change (TTM)
43.83%
Earnings per share change (TTM)
-101.42%
3-year revenue growth
34.76%
3-year earnings per share growth
-72.80%
What the Analysts think about SRPT
Analyst Ratings
Majority rating from 23 analysts.
SRPT Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$413M
4.21%
Net income
$36M
-20.83%
Profit margin
8.73%
-24.02%
SRPT Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.27
-$0.46
$0.47
$0.37
-
Expected
-$1.78
-$1.23
$0.01
-$0.07
-$0.02
Surprise
-84.81%
-62.62%
3,083.20%
-625.68%
-
SRPT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sarepta Therapeutics stock?
Sarepta Therapeutics (SRPT) has a market cap of $15B as of July 03, 2024.
What is the P/E ratio for Sarepta Therapeutics stock?
The price to earnings (P/E) ratio for Sarepta Therapeutics (SRPT) stock is 856.46 as of July 03, 2024.
Does Sarepta Therapeutics stock pay dividends?
No, Sarepta Therapeutics (SRPT) stock does not pay dividends to its shareholders as of July 03, 2024.
When is the next Sarepta Therapeutics dividend payment date?
Sarepta Therapeutics (SRPT) stock does not pay dividends to its shareholders.
What is the beta indicator for Sarepta Therapeutics?
Sarepta Therapeutics (SRPT) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Sarepta Therapeutics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.